Inhibiting P2Y12 receptor relieves LPS‐induced inflammation and endothelial dysfunction
Abstract Background Acute lung injury (ALI) is characterized by abnormal inflammatory response without effective therapies. P2Y12 receptor (P2Y12R) plays a vital role in inflammatory response. This study intends to explore whether P2Y12R antagonists can inhibit LPS‐induced inflammatory injury of hum...
Main Author: | Xiuxia Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.697 |
Similar Items
-
Role of P2Y Receptors in Platelet Extracellular Vesicle Release
by: Aleksandra Gąsecka, et al.
Published: (2020-08-01) -
P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Po-Wei Chen, et al.
Published: (2020-06-01) -
Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock
by: Vojko Kanic, et al.
Published: (2024-01-01) -
Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry
by: Sukhdeep S. Basra, et al.
Published: (2018-06-01) -
Clinical outcomes with the use of ticagrelor or clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction – A prospective observational study
by: Bibek Agarwal, et al.
Published: (2022-01-01)